Filer Snapshot

Arjun Goyal

CIK 0001861844. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

10

Latest filing

24 Jun 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for CNTA. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 24 Jun 2026 for CIK 0001861844.

View source filing
Business address
C/O Centessa Pharmaceuticals Plc, 3 Rd Floor, 1 Ashley Road, Altrincham, Cheshire, United Kingdom, WA14 2DT

Filer intelligence

What SEC filings say about Arjun Goyal

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for CNTA worth $0.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 2 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

CNTA

24 Jun 2026

$0

JATT II Acquisition Corp.

16 Apr 2026

Latest update

What changed recently for Arjun Goyal

Ownership report updated

Latest ownership report period: 24 Jun 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

24 Jun 2026

Page type

Ownership filings

Latest period

24 Jun 2026

Ownership context was refreshed from SEC Forms 3/4/5 filed on 24 Jun 2026.

SEC filing record

CIK 0001861844 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
10
First seen
27 May 2021
Latest filing
24 Jun 2026
Entity
Individual

Observed form types

4 3

Latest Filings

Showing the latest 10 of 10 SEC filings for Arjun Goyal.

4 File 001-40445

FORM 4

Filing date
24 Jun 2026
Reporting date
24 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-43237

3 filing

Filing date
17 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40445

FORM 4

Filing date
24 Jun 2025
Reporting date
20 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40445

FORM 4

Filing date
19 May 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40445

FORM 4

Filing date
27 Jun 2024
Reporting date
25 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40445

FORM 4

Filing date
23 Jun 2023
Reporting date
22 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40445

FORM 4 SUBMISSION

Filing date
05 Jul 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40445

FORM 4 SUBMISSION

Filing date
06 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40445

FORM 4 SUBMISSION

Filing date
04 Jun 2021
Reporting date
02 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-40445

FORM 3 SUBMISSION

Filing date
27 May 2021
Reporting date
27 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .